# Erlotinib

## Tarceva 150mg

#### 本院臨採清單

| 藥品代碼       | OTAR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|:---------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症         | Treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) after failure of at least 1 prior chemotherapy regimen.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 用法用量       | [Non–small cell lung cancer (NSCLC) (as first-line therapy， maintenance treatment， or for progressive disease)] 150 mg taken on an empty stomach at least 1 hour before or 2 hours after the ingestion of food. Treatment should continue until disease progression or unacceptable toxicity occurs.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 肝功能異常     | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 腎功能異常     | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 禁忌           | nan                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 副作用         | Rash， diarrhea， anorexia， fatigue， dyspnea， cough， nausea， vomiting， stomatitis， pruritus， dry skin， conjunctivitis， keratoconjunctivitis sicca， abdominal pain. Rarely， elevated liver enzymes， GI bleeding (in association with concomitant administration of warfarin or NSAIDs). Cardiovascular: Edema (37% ) Dermatologic: Alopecia (14% )， Pruritus (7.4% to 13% )， Rash， Any grade (49.2% to 75% ) Endocrine metabolic: Weight decreased (3.9% to 39% ) Gastrointestinal: Abdominal pain (11% to 46% )， Diarrhea， Any grade (20.3% to 54% )， Flatulence (13% )， Indigestion (17% )， Inflammatory disease of mucous membrane (17% to 22% )， Loss of appetite (9.2% to 52% )， Nausea (33% to 60% )， Vomiting (23% to 42% ) Hepatic: Hyperbilirubinemia， Increased liver enzymes Immunologic: Infectious disease (39% ) Musculoskeletal: Bone pain (25% )， Myalgia (21% ) Neurologic: Headache (15% ) Ophthalmic: Conjunctivitis (12% )， Keratoconjunctivitis sicca (12% ) Psychiatric: Anxiety (13% )， Depression (19% ) Respiratory: Cough (16% to 33% )， Dyspnea (24% to 41% ) Other: Fatigue (9% to 73% )， Fever (36% ) |
| 孕期用藥建議   | nan                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 哺乳期用藥建議 | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |

